In the past few years, several studies have identified a potential link between Zofran (ondansetron) and an increased risk of birth defects. Harvard and Boston University Review This 2012 epidemiological review of more than 10,000 birth records found that women who were prescribed Zofran as an off-label treatment for morning sickness were over twice as […]
SOURCE: The Legal Examiner – Read entire story here.
